Pacira BioSciences
Logotype for Pacira BioSciences Inc

Pacira BioSciences (PCRX) investor relations material

Pacira BioSciences 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Pacira BioSciences Inc
44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026

Business Overview and Strategic Vision

  • Focused on innovative, non-opioid pain management, helping over 18 million patients and generating $726 million in unaudited 2025 sales with 800+ employees.

  • Mission centers on delivering transformative pain therapies, guided by patient-centricity, scientific rigor, integrity, and team diversity.

  • 5x30 strategy targets growth and value creation by 2030, focusing on musculoskeletal pain and adjacent markets.

  • Portfolio includes EXPAREL (flagship nerve block), ZILRETTA (corticosteroid for osteoarthritis), and iovera (cryoneurolysis device).

  • Achieved 40%+ stock price increase and highest historical margins, driven by manufacturing efficiency and robust commercial organization.

Strategic Initiatives, Partnerships, and Global Expansion

  • Launched 5x30 strategy: help 3 million patients, double-digit top-line growth, five-point margin expansion, five new pipeline programs, and five partnerships by 2030.

  • Signed key partnerships with Johnson & Johnson (tripling ZILRETTA reach) and LG Chem (Asia-Pacific commercial rights for EXPAREL and potential ZILRETTA sales), with regulatory filings planned for South Korea and Thailand in 2026.

  • Acquired GQ Bio, securing the HCAd platform for PCRX-201 and initiated three preclinical programs (dry eye, degenerative disc disease, canine IL-1Ra).

  • Five partnerships established, supporting global expansion and pipeline advancement.

  • Settled with Fresenius and Hengrui, extending EXPAREL market visibility to 2039 and expanded IP estate to 21 patents.

Commercial Performance, Market Access, and Adoption

  • NOPAIN legislation provides separate reimbursement for 11 products, including EXPAREL and iovera, at ASP plus 6 for Medicare outpatients.

  • Covered lives reached 102 million in 2025, with early uptake in ambulatory surgery centers and smaller hospitals.

  • Over 90% of EXPAREL business now contracted, supporting steady volume and top-line growth.

  • Real-world evidence and HEOR data support expanded utilization and formulary wins.

  • 82% of surveyed stakeholders view NOPAIN as important for non-opioid stewardship; 92% believe it reduces opioid prescribing.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Pacira BioSciences earnings date

Logotype for Pacira BioSciences Inc
Q4 202526 Feb, 2026
Pacira BioSciences
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Pacira BioSciences earnings date

Logotype for Pacira BioSciences Inc
Q4 202526 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Pacira BioSciences Inc. is a pharmaceutical company focused on developing and commercializing non-opioid pain management and regenerative health solutions. The company's primary offerings include products designed to provide long-lasting pain relief for patients undergoing surgical procedures. Pacira BioSciences serves the healthcare sector, working with hospitals, ambulatory surgery centers, and healthcare providers to reduce reliance on opioids and improve patient outcomes through its innovative treatments. The company is headquartered in Tampa, Florida, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage